Pro Medicus shares soar on $330m deal with US' Trinity Health
Make us a preferred source
Make us a preferred source on Google
The news: Pro Medicus shares have rocketed after it announced its subsidiary Visage Imaging has signed a contract with Trinity Health in the US. The agreement will see the healthcare provider use Visage’s cloud-based imaging platform throughout its locations.
The numbers: Pro Medicus shares were up 9.6% to $250.17 by 1:50pm AEDT. Over the last 12 months they have surged 186.2%.
The 10-year deal is worth $330 million and will see the Visage 7 platform used by over 650 radiologists and thousands of clinicians.
Trinity Health has 93 hospitals, 107 continuing care locations, 142 urgent care locations, and other health and well-being services across the US.
The context: The contract includes the company’s Visage 7 Viewer, Visage 7 Open Archive and Visage 7 Workflow modules.
Planning of platform rollout will commence immediately and is targeted to go live in early Q3 of the 2025 calendar year.
On Wednesday, Pro Medicus signed a $24 million deal with US medical centre NYU Langone Health for its Visage 7 product suite.
What they said: Pro Medicus chief executive Sam Hupert said: “Trinity Health is our largest customer to date and the first with a national footprint”.
“... As has been the case with many of our recent contracts, this deal is for our ‘full-stack’ comprising all three core Visage products, a trend we see continuing.”
The source: ASX announcement
